Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Guangdong Provincial People's Hospital
Zhujiang Hospital
Mayo Clinic
Emory University
Fudan University
Peking Union Medical College Hospital
Başakşehir Çam & Sakura City Hospital
Tongji Hospital
Assiut University
Latin American Cooperative Oncology Group
Assiut University
Centre Leon Berard